Description:

GOG-0241 Treatment Completion Form (Q0) Carboplatin and Paclitaxel or Oxaliplatin and Capecitabine, With or Without Bevacizumab, as First-Line Therapy in Treating Patients With Newly Diagnosed Stage II, Stage III, Stage IV, or Recurrent Stage I Epithelial Ovarian Cancer or Fallopian Tube Cancer Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D1826DA-E893-F792-E040-BB89AD433BF7

Link:

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8D1826DA-E893-F792-E040-BB89AD433BF7

Keywords:
Versions (2) ▾
  1. 9/19/12
  2. 1/8/15
Uploaded on:

January 8, 2015

DOI:
No DOI assigned. To request one please log in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Fallopian Tube Cancer NCT01081262 Off Treatment - GOG-0241 Treatment Completion Form (Q0) - 3127331v1.0

No Instruction available.

  1. StudyEvent: GOG-0241 Treatment Completion Form (Q0)
    1. No Instruction available.
Header Module
Treatment Schedule
Off-treatment Reason
Reason Treatment Ended (check only one)
Will patient receive further treatment?
Best Tumor Response

Similar models